In Vivo Therapeutic Articles & Analysis
9 articles found
In June 2025, Capstan Therapeutics announced the initiation of a Phase I clinical trial for CPTX2309, an in vivo CAR-T candidate targeting B-cell–mediated autoimmune diseases. ...
Understanding their intricate interplay is essential for determining the efficacy and safety of therapeutic compounds. When studied in living organisms, this relationship is referred to as in vivo PK/PD, a discipline that provides invaluable insights into drug behavior within a biological context. ...
Copper-Free Click Chemistry for Imaging The biocompatibility and selectivity of copper-free click chemistry have facilitated its application in in vivo imaging. For example, dibenzocyclooctyne (DBCO) click chemistry reagents can be used in the development of bioorthogonal probes and contrast agents for in vivo imaging applications. ...
While KineTAC demonstrated excellent results in in vitro experiments, its in vivo experiments have not been extensively explored. Only pharmacokinetic studies have been presented, leaving room for further animal experiments to validate whether the in vitro effective dose might lead to potential "cytokine storm" side effects in vivo due to the intensity of ...
This refers to a cryomicroneedle shorter than 1 mm, which is loaded and stored with living mammalian cells in vivo and delivers therapeutic cells into the skin layer. When administering the drug, the patch-shaped device loaded with cryomicroneedle arrays is placed on the skin, and the cryomicroneedles penetrate into the skin, detach from the base of the device ...
Precautions All MyBioSource products are for scientific laboratory research purposes and not for diagnostic, therapeutic, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Product purchased from MyBioSource in accordance with industry standards. ...
This dual approach was observed to provide higher level of vascularization and new bone formation in vivo. While applied in this case for bone regeneration, this technique could be easily adapted to prevascularise scaffolds to target regeneration of any tissue and organs. ...
ByRegenhu
Introduction The terminal sialic acids on the carbohydrate side chains of glycoproteins have a major impact on their overall properties, including their circulatory half-lives in vivo (Ngantung et al., 2006). Therefore, recombinant glycoprotein biologics intended for human therapeutic applications are usually manufactured in mammalian cell systems, which have ...
New technologies are emerging that are leading to the development of highly intelligent, implantable sensors, activators, and mobile robots that will provide in vivo diagnosis, therapeutic interventions, and functional replacement. ...